{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:18:56Z","timestamp":1792063136472,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this study, we compare the predictive value of clinical scoring systems that are already in use in patients with Coronavirus disease 2019 (COVID-19), including the Brescia-COVID Respiratory Severity Scale (BCRSS), Quick SOFA (qSOFA), Sequential Organ Failure Assessment (SOFA), Multilobular infiltration, hypo-Lymphocytosis, Bacterial coinfection, Smoking history, hyper-Tension, and Age (MuLBSTA) and scoring system for reactive hemophagocytic syndrome (HScore), for determining the severity of the disease. Our aim in this study is to determine which scoring system is most useful in determining disease severity and to guide clinicians. We classified the patients into two groups according to the stage of the disease (severe and non-severe) and adopted interim guidance of the World Health Organization. Severe cases were divided into a group of surviving patients and a deceased group according to the prognosis. According to admission values, the BCRSS, qSOFA, SOFA, MuLBSTA, and HScore were evaluated at admission using the worst parameters available in the first 24\u00a0h. Of the 417 patients included in our study, 46 (11%) were in the severe group, while 371 (89%) were in the non-severe group. Of these 417 patients, 230 (55.2%) were men. The median (IQR) age of all patients was 44 (25) years. In multivariate logistic regression analyses, BRCSS in the highest tertile (HR 6.1, 95% CI 2.105\u201317.674, p\u2009=\u20090.001) was determined as an independent predictor of severe disease in cases of COVID-19. In multivariate analyses, qSOFA was also found to be an independent predictor of severe COVID-19 (HR 4.757, 95% CI 1.438\u201315.730, p\u2009=\u20090.011). The area under the curve (AUC) of the BRCSS, qSOFA, SOFA, MuLBSTA, and HScore was 0.977, 0.961, 0.958, 0.860, and 0.698, respectively. Calculation of the BRCSS and qSOFA at the time of hospital admission can predict critical clinical outcomes in patients with COVID-19, and their predictive value is superior to that of HScore, MuLBSTA, and SOFA. Our prediction is that early interventions for high-risk patients, with early identification of high-risk group using BRCSS and qSOFA, may improve clinical outcomes in COVID-19.<\/jats:p>","DOI":"10.1038\/s41598-021-01181-x","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T11:04:19Z","timestamp":1636369459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-9010","authenticated-orcid":false,"given":"Ishak","family":"San","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9751-8452","authenticated-orcid":false,"given":"Emin","family":"Gemcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3448-6454","authenticated-orcid":false,"given":"Salih","family":"Baser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1918-3412","authenticated-orcid":false,"given":"Nuray","family":"Yilmaz Cakmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-2018","authenticated-orcid":false,"given":"Abdulsamet","family":"Erden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9856-2391","authenticated-orcid":false,"given":"Seval","family":"Izdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-9873","authenticated-orcid":false,"given":"Ramis","family":"Catalbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-8885","authenticated-orcid":false,"given":"Mehmet","family":"Davutoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-7610","authenticated-orcid":false,"given":"Berkan","family":"Karabuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2858-6229","authenticated-orcid":false,"given":"Ihsan","family":"Ates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"issue":"8","key":"1181_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287 (2016).","journal-title":"JAMA"},{"issue":"5","key":"1181_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.20452\/pamw.15312","volume":"130","author":"Q Yao","year":"2020","unstructured":"Yao, Q. et al. A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients. Pol. Arch. Intern. Med. 130(5), 390\u2013399. https:\/\/doi.org\/10.20452\/pamw.15312 (2020).","journal-title":"Pol. Arch. Intern. Med."},{"key":"1181_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour, C. W. et al. Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 762\u2013774 (2016).","journal-title":"JAMA"},{"key":"1181_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2020.01.107","author":"T Kr\u00f3licki","year":"2020","unstructured":"Kr\u00f3licki, T. et al. Systemic inflammatory markers predict detrimental outcome of urosepsis in kidney transplant recipients. Transplant. Proc. https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.107 (2020).","journal-title":"Transplant. Proc."},{"key":"1181_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.2016.20329","volume":"317","author":"Y Freund","year":"2017","unstructured":"Freund, Y. et al. Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 317, 301\u2013308. https:\/\/doi.org\/10.1001\/jama.2016.20329 (2017).","journal-title":"JAMA"},{"issue":"1","key":"1181_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-020-00664-w","volume":"10","author":"M Ferreira","year":"2020","unstructured":"Ferreira, M. et al. Critically ill SARS-CoV-2-infected patients are not stratified as sepsis by the qSOFA. Ann. Intensive Care. 10(1), 43. https:\/\/doi.org\/10.1186\/s13613-020-00664-w (2020).","journal-title":"Ann. Intensive Care."},{"issue":"10223","key":"1181_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395(10223), 507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7 (2020).","journal-title":"Lancet"},{"key":"1181_CR8","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.3389\/fmicb.2019.02752","volume":"10","author":"L Guo","year":"2019","unstructured":"Guo, L. et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA Score. Front. Microbiol. 10, 2752 (2019).","journal-title":"Front. Microbiol."},{"issue":"1","key":"1181_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12967-020-02374-0","volume":"18","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J. Transl. Med. 18(1), 206. https:\/\/doi.org\/10.1186\/s12967-020-02374-0 (2020).","journal-title":"J. Transl. Med."},{"key":"1181_CR10","first-page":"451","volume":"11","author":"JL Stephan","year":"1993","unstructured":"Stephan, J. L. et al. Macrophage activation syndrome and rheumatic disease in childhood: A report of four new cases. Clin. Exp. Rheumatol. 11, 451\u2013456 (1993).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1181_CR11","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet, L. et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 66, 2613\u20132620 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"1181_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"issue":"10229","key":"1181_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395(10229), 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"1181_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16934.10.1111\/bjh.16934","author":"H Wood","year":"2020","unstructured":"Wood, H. et al. Secondary HLH is uncommon in severe COVID-19. Br. J. Haematol. https:\/\/doi.org\/10.1111\/bjh.16934.10.1111\/bjh.16934 (2020).","journal-title":"Br. J. Haematol."},{"key":"1181_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcrc.2020.04.004","volume":"58","author":"S Piva","year":"2020","unstructured":"Piva, S. et al. Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. J. Crit. Care. 58, 29\u201333 (2020).","journal-title":"J. Crit. Care."},{"issue":"2","key":"1181_CR16","first-page":"143","volume":"28","author":"Lombardy Section Italian Society Infectious and Tropical Diseases","year":"2020","unstructured":"Lombardy Section Italian Society Infectious and Tropical Diseases. Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020. Infez. Med. 28(2), 143\u2013152 (2020).","journal-title":"Infez. Med."},{"issue":"207","key":"1181_CR17","first-page":"1","volume":"14","author":"J-L Vincent","year":"2010","unstructured":"Vincent, J.-L. & Moreno, R. Clinical review: Scoring system in the critically ill. Crit. Care 14(207), 1\u20139 (2010).","journal-title":"Crit. Care"},{"issue":"4","key":"1181_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1399-6576.2008.01586.x","volume":"52","author":"K Strand","year":"2008","unstructured":"Strand, K. & Flaatten, H. Severity scoring in the ICU: Review. Acta Anaesthesiol. Scand. 52(4), 467\u2013478 (2008).","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"1","key":"1181_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/CCM.0b013e3181f96f81","volume":"39","author":"MT Keegan","year":"2011","unstructured":"Keegan, M. T., Gajic, O. & Afessa, B. Severity of illness scoring systems in the intensive care unit. Crit. Care Med. 39(1), 163\u2013169 (2011).","journal-title":"Crit. Care Med."},{"key":"1181_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12519-020-00362-4","volume":"16","author":"KL Shen","year":"2020","unstructured":"Shen, K. L. et al. Updated diagnosis, treatment and prevention of COVID-19 in children: Experts\u2019 consensus statement (condensed version of the second edition). World J. Pediatr. 16, 232\u2013239 (2020).","journal-title":"World J. Pediatr."},{"issue":"9","key":"1181_CR21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1080\/23744235.2020.1776381","volume":"52","author":"ME Tezcan","year":"2020","unstructured":"Tezcan, M. E., Do\u011fan G\u00f6k\u00e7e, G. & Ozer, R. S. Laboratory abnormalities related to prolonged hospitalization in COVID-19. Infect. Dis. (Lond). 52(9), 666\u2013668. https:\/\/doi.org\/10.1080\/23744235.2020.1776381 (2020).","journal-title":"Infect. Dis. (Lond)."},{"key":"1181_CR22","unstructured":"WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance. (2020). https:\/\/apps.who.int\/iris\/handle\/10665\/330854.\nAccessed 25 Jan 2020."},{"key":"1181_CR23","unstructured":"Ministry TH. Turkish Health Ministry. Guidance To Covid-19 (SARS Cov2 Infection).  https:\/\/hsgm.saglik.gov.tr\/tr\/covid-19-ingilizce-dokumanlar.html. Accessed 8 June 2020."},{"key":"1181_CR24","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","volume":"286","author":"FL Ferreira","year":"2001","unstructured":"Ferreira, F. L. et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286, 1754\u20131758 (2001).","journal-title":"JAMA"},{"key":"1181_CR25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2147\/RMHP.S263095","volume":"13","author":"ZH Wang","year":"2020","unstructured":"Wang, Z. H., Shu, C., Ran, X., Xie, C. H. & Zhang, L. Critically ill patients with coronavirus disease 2019 in a designated ICU: Clinical features and predictors for mortality. Risk Manag. Healthc. Policy. 13, 833\u2013845. https:\/\/doi.org\/10.2147\/RMHP.S263095 (2020).","journal-title":"Risk Manag. Healthc. Policy."},{"issue":"1","key":"1181_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13613-020-00706-3","volume":"10","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Clinical outcomes of COVID-19 in Wuhan, China: A large cohort study. Ann. Intensive Care. 10(1), 99. https:\/\/doi.org\/10.1186\/s13613-020-00706-3 (2020).","journal-title":"Ann. Intensive Care."},{"issue":"3","key":"1181_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11739-017-1629-5","volume":"13","author":"F Innocenti","year":"2018","unstructured":"Innocenti, F. et al. SOFA score in septic patients: Incremental prognostic value over age, comorbidities, and parameters of sepsis severity. Intern. Emerg. Med. 13(3), 405\u2013412. https:\/\/doi.org\/10.1007\/s11739-017-1629-5 (2018).","journal-title":"Intern. Emerg. Med."},{"issue":"25","key":"1181_CR28","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e234","volume":"35","author":"JG Jang","year":"2020","unstructured":"Jang, J. G., Hur, J., Hong, K. S., Lee, W. & Ahn, J. H. Prognostic accuracy of the SIRS, qSOFA, and NEWS for early detection of clinical deterioration in SARS-CoV-2 infected patients. J. Korean Med. Sci. 35(25), e234. https:\/\/doi.org\/10.3346\/jkms.2020.35.e234 (2020).","journal-title":"J. Korean Med. Sci."},{"key":"1181_CR29","doi-asserted-by":"publisher","first-page":"100448","DOI":"10.1016\/j.eclinm.2020.100448","volume":"24","author":"S Almazeedi","year":"2020","unstructured":"Almazeedi, S. et al. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine. 24, 100448. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100448 (2020).","journal-title":"EClinicalMedicine."},{"key":"1181_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102880","volume":"57","author":"LS Xiao","year":"2020","unstructured":"Xiao, L. S. et al. Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019. EBioMedicine 57, 102880. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102880 (2020).","journal-title":"EBioMedicine"},{"key":"1181_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23475","author":"J Peng","year":"2020","unstructured":"Peng, J. et al. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study. J. Clin. Lab. Anal https:\/\/doi.org\/10.1002\/jcla.23475 (2020).","journal-title":"J. Clin. Lab. Anal"},{"key":"1181_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s13312-020-1962-z","volume":"57","author":"S Bhattacharjee","year":"2020","unstructured":"Bhattacharjee, S., Banerjee, M. & Pal, R. COVID-19-associated hemophagocytic lymphohistiocytosis and coagulopathy: Targeting the duumvirate. Indian Pediatr. 57, 827\u2013833 (2020).","journal-title":"Indian Pediatr."},{"issue":"9","key":"1181_CR33","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/annrheumdis-2020-218048","volume":"79","author":"P Ruscitti","year":"2020","unstructured":"Ruscitti, P. et al. Lung involvement in macrophage activation syndrome and severe COVID-19: Results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences. Ann. Rheum. Dis. 79(9), 1152\u20131155. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218048 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1181_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04636-y","author":"M Soy","year":"2020","unstructured":"Soy, M., Atag\u00fcnd\u00fcz, P., Atag\u00fcnd\u00fcz, I. & Sucak, G. T. Hemophagocytic lymphohistiocytosis: A review inspired by the COVID-19 pandemic. Rheumatol. Int. https:\/\/doi.org\/10.1007\/s00296-020-04636-y (2020).","journal-title":"Rheumatol. Int."},{"issue":"10236","key":"1181_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31057-6","volume":"395","author":"DL Leverenz","year":"2020","unstructured":"Leverenz, D. L. & Tarrant, T. K. Is the HScore useful in COVID-19?. Lancet 395(10236), e83. https:\/\/doi.org\/10.1016\/S0140-6736(20)31057-6 (2020).","journal-title":"Lancet"},{"issue":"1","key":"1181_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/03009742.2016.1167951","volume":"46","author":"ED Batu","year":"2017","unstructured":"Batu, E. D. et al. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases. Scand. J. Rheumatol. 46(1), 44\u201348. https:\/\/doi.org\/10.3109\/03009742.2016.1167951 (2017).","journal-title":"Scand. J. Rheumatol."},{"key":"1181_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102568","volume":"19","author":"P Toniati","year":"2020","unstructured":"Toniati, P. et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun. Rev. 19, 102568. https:\/\/doi.org\/10.1016\/j.autrev.2020.102568 (2020).","journal-title":"Autoimmun. Rev."},{"key":"1181_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102523","author":"O Moreno-P\u00e9rez","year":"2020","unstructured":"Moreno-P\u00e9rez, O. et al. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study. J. Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2020.102523 (2020).","journal-title":"J. Autoimmun."},{"key":"1181_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26473.10.1002\/jmv.26473","author":"A Erden","year":"2020","unstructured":"Erden, A. et al. Evaluation of seventeen patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA and Brescia-COVID respiratory severity scale (BCRSS) scoring systems. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.26473.10.1002\/jmv.26473 (2020).","journal-title":"J. Med. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01181-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:15:57Z","timestamp":1670087757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01181-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1181"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-01181-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21807"}}